Personalized brain stimulation for hard-to-treat epilepsy
Part of Brain & nervous system clinical trials.
This study tests a personalized, non-invasive brain stimulation method called tDCS for people with drug-resistant epilepsy that starts in one part of the brain. It aims to reduce seizures in those who cannot have surgery or have not been helped by surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 9 years or older.
- You have been diagnosed with drug-resistant epilepsy that starts in one area of the brain (focal epilepsy) and has not responded to at least two medications.
- You have had at least 3 seizures per month in the last month.
- Your epilepsy medication doses have been stable for at least 4 weeks before the study begins.
- You are able to speak, read, and write in French, and can follow study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized brain stimulation method (transcranial electrical stimulation) to reduce seizures in children with hard-to-control partial epilepsy. It aims to find the best stimulation spot and settings for each patient by using advanced brain scans.
This study tests a new type of brain stimulation called temporal interference to help people with epilepsy that hasn't responded well to medications. Researchers want to see if this approach can reduce seizures and improve thinking or memory problems.
This trial tests if transcranial magnetic stimulation (TMS, a non-invasive brain stimulation) targeting the cerebellum can safely reduce seizures over time in people with drug-resistant epilepsy. It aims to find a new treatment option for those whose seizures aren't controlled by medication.
This study uses a special type of brain stimulation (transcranial magnetic stimulation, or TMS) to measure how well epilepsy medications are working in adults with epilepsy.
This trial tests a type of brain stimulation therapy (TIS) for people with temporal lobe epilepsy that hasn't responded well to seizure medications. The goal is to help reduce how often seizures happen.
This study is looking at how well a procedure called SEEG thermocoagulation (a way to stop seizures by heating a small area of brain tissue) works for people with epilepsy that doesn't improve with medication. By joining, you will help doctors understand why this treatment works for some people and not others.
Hear when a new Epilepsy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.